Cerebral Board Members Agree to Replace CEO Amid Federal Probe Into Prescription Practices

Directors control the board of directors of Cerebral Inc. agreed on a plan to replace the CEO Kyle Robertsonsparking leadership anxiety at the mental health startup as it faces scrutiny over its prescription practices for controlled substances, people familiar with the situation say. picture said Tuesday.

Some said investors and an independent director who jointly controls four of the seven board seats agreed that Mr Robertson should be replaced by the company’s chairman and chief medical officer, David Mou. Mr. Robertson, who co-founded Cerebral and controls three other seats, did not attend the meeting, but he later lost access to the company’s Slack messaging system without notice, said another person. said. Mr. Robertson did not agree to step down from his CEO role late Tuesday, the people said.

https://www.wsj.com/articles/cerebral-board-members-agree-to-replace-ceo-amid-federal-probe-into-prescription-practices-11652840097?mod=pls_whats_news_us_business_f Cerebral Board Members Agree to Replace CEO Amid Federal Probe Into Prescription Practices

Edmund DeMarche

USTimesPost.com is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@ustimespost.com. The content will be deleted within 24 hours.

Related Articles

Back to top button